Source: Amnesty International –
Responding to the launch of Medact’s (an organisation bringing together health workers in the UK) latest briefing that outlines grave human rights concerns and risks posed by contracting Palantir to build NHS England’s Federated Data Platform (FDP), Matt Mahmoudi, Researcher and Advisor on Artificial Intelligence and Human Rights at Amnesty International said:
“Amnesty International supports the briefing published by Medact and partners exposing why Palantir’s is an unsuitable partner for National Health Services (NHS) England due to significant human rights concerns associated with the company. Palantir has a track record of flagrantly disregarding international law and standards, both in the violations of the human rights of migrants in the United States, to which it risks contributing to, and its ongoing supply of artificial intelligence (AI) products and services to the Israeli military and intelligence services that are linked to Israel’s ongoing genocide in Gaza.
“Amnesty International is calling on NHS England, the UK government and all other public institutions to use their leverage from their investments, including by responsibly divesting from Palantir and ceasing the purchase of equipment and services from the company. These measures must remain in place until the company can demonstrate that it is not contributing to Israel’s genocide, apartheid, unlawful occupation or other crimes under international law.”